John Roberts, MD

Organ transplant surgeon

Dr. John Roberts is a surgeon with expertise that includes kidney, liver and pancreas transplants. He is also an expert in surgically managing liver diseases, such as portal hypertension (high blood pressure in the vein going from the digestive organs to the liver), as well as in liver surgery for cancer.

Roberts is one of the few surgeons in the U.S. who has extensive experience in performing the Rex shunt – a procedure that restores normal blood flow to the liver – in children and adults. He also has spearheaded an effort to expand the use of living donors for liver transplantation, one of his many projects to make more organs available.

Roberts earned his medical degree at the University of California, San Diego and completed a surgical residency at the University of Washington. He also served as a postdoctoral fellow in transplantation in the Department of Surgery at the University of Minnesota Medical School.

Roberts joined UCSF Medical Center in 1988. In addition to his leadership of the transplant service, he teaches medical students and supervises the training of surgical residents.

Roberts has won numerous awards and has received grants from the National Institutes of Health for his research. He has produced nearly 170 papers on topics that include organ transplant rejection, immunogenicity (ability of a substance to provoke an immune response) and immunosuppression (intentionally subduing immune response to lower the chance of organ rejection).

Roberts speaks nationally on transplant issues. He is a fellow of the American Surgical Association and a member of many professional organizations.

Clinics

Kidney Transplant Program
1825 Fourth St., Sixth Floor
San Francisco, CA 94158

Liver Transplant Program
1825 Fourth St., Sixth Floor
San Francisco, CA 94158

Conditions & Treatments

More about John Roberts

Education

UC San Diego 1980

Residencies

University of Washington, Surgery 1983

Fellowships

University of Minnesota, Transplant Surgery 1987

Selected Research and Publications

  1. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. Increasing Liver Transplant Waitlist Dropout for Hepatocellular Carcinoma with Widening Geographical Disparities: Implications for Organ Allocation. Liver Transpl. 2018 Aug 01.
  2. Manuel SP, Roberts JP, Bakhtary S. Preoperative autologous blood collection in adult living liver donors: Are we wasting donor blood and increasing exposure to risk? Transplantation. 2018 Jun 26.
  3. Samoylova ML, Mehta N, Roberts JP, Yao FY. Predictors of ultrasound failure to detect hepatocellular carcinoma. Liver Transpl. 2018 May 21.
  4. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Reply (to LTE HEP-17-2332). Hepatology. 2018 Jan 29.
  5. Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY. Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma. Transplantation. 2018 Jan 17.
  6. Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY. Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study. Clin Gastroenterol Hepatol. 2017 Nov 23.
  7. Shaw BI, Burdine LJ, Braun HJ, Ascher NL, Roberts JP. A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference. Transplant Direct. 2017 Dec; 3(12):e225.
  8. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form. Clin Transplant. 2017 Nov; 31(11).
  9. Orandi BJ, Luo X, King EA, Garonzik-Wang JM, Bae S, Montgomery RA, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Osama Gaber A, Segev DL. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. Am J Transplant. 2018 Mar; 18(3):650-658.
  10. Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation. 2017 09; 101(9):2079-2082.
  11. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation. 2017 09; 101(9):2071-2078.
  12. Samoylova ML, Nigrini MJ, Dodge JL, Roberts JP. Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list. Hepatology. 2017 10; 66(4):1144-1150.
  13. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017 08; 66(2):564-574.
  14. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 08; 23(8):1015-1022.
  15. Ge J, Roberts JP, Lai JC. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States. Clin Transplant. 2017 Aug; 31(8).
  16. Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC. Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008.
  17. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol. 2017 Apr 01; 3(4):493-500.
  18. Cai L, Yeh BM, Westphalen AC, Roberts J, Wang ZJ. 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors. Abdom Radiol (NY). 2017 Mar; 42(3):842-850.
  19. Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. Liver Transpl. 2017 03; 23(3):292-298.
  20. Choi WT, Jen KY, Wang D, Tavakol M, Roberts JP, Gill RM. Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection. Am J Surg Pathol. 2017 Mar; 41(3):365-373.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.